Samsung Bioepis Partners with Chinese Biotech Firm for Antibody-Drug Conjugates
Seoul: Samsung Bioepis Co., a biopharmaceutical unit under Samsung Group, announced a collaboration with Chinese biotech firm Phrontline Biopharma to co-develop, manufacture, and commercialize antibody-drug